Boya Bio-Pharmaceutical Group

Boya Bio-Pharmaceutical Group Co., Ltd. is a China-based company specializing in the development, production, and sale of a wide range of medical and health products. Founded in 1993 and headquartered in Fuzhou, the company offers various blood products, including human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, and human albumin. In addition to blood products, Boya Bio-Pharmaceutical Group produces biochemical drugs and chemical medicines, addressing various health conditions with products for orthopedics, obstetrics, gynecology, gastrointestinal issues, and diabetes. The company's portfolio also features active pharmaceutical ingredients and a focus on innovative formulations, including anti-diabetic medications and treatments for diabetic complications. Through its diverse product offerings, the company aims to meet the growing healthcare needs in China.